A Juno and Celgene collaboration will focus on T cell therapeutics for cancer, one in eight people is pre-diabetic but a new study shows a willingness to change behavior if made aware of their risk.
Neil Versel | 3:30 pm, July 2
Meghana Keshavan | 2:47 pm, July 2
Chris Seper | 9:46 am, July 1
Last week in Medcity News, Tiffany Wilson Karp, the executive director of the Global Center for Medical Innovation, discussed the changing landscape for early stage funding in the medical device space. As Karp observes, a partnership between a start-up and corporate venture arm can be ideal. There are, however, potential pitfalls to such a relationship.